UCLA CENTER FOR AIDS RESEARCH (CFAR)
UCLA CENTER FOR AIDS RESEARCH (CFAR)
批准号:
6510427
负责人:
IRVIN S.Y. CHEN
金额:
$163.4万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-01 至 2003-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This application constitutes a renewal on the part of the University of
California/Los Angeles (UCLA) for a Center for AIDS Research (CFAR) grant.
This grant will fund activities and programs conducted by the UCLA AIDS
Institute. The UCLA AIDS Institute was established in 1992 to coordinate
all AIDS research, clinical and educational activities at the University
and its seven affiliated teaching hospitals under one central
administration. Dr. S.Y. Chen was appointed the founding and current
Director of the AIDS Institute and is also the Principal Investigator of
the UCLA CFAR. This renewal application includes core services and
activities described herein that are designed to advance knowledge of
HIV/AIDS through the basic, clinical, and behavioral sciences. The overall
goal is to develop therapies and approaches to prevent and ultimately
eliminate the threat of HIV/AIDS. The Institute consists of more than 150
faculty investigators responsible for over 200 research projects that
encompass various aspects of HIV/AIDS biology, clinical studies, and
behavioral science investigations. UCLA has consistently been ranked among
the top five institutions by various sources for its excellence in AIDS
research, education and teaching, and clinical programs. Metropolitan Los
Angeles is a major epicenter for the AIDS epidemic and one of the most
culturally diverse regions in the nation. The role of the Institute is to
foster collaboration and build linkages both within and outside the
university. Its emphasis is on the development of innovate approaches
through the formation of multidisciplinary collaborations and provision of
key technologies through core facilities to all AIDS researchers in UCLA.
Additionally, the Institute is proactive in providing an "investigator
friendly" environment to external research efforts that fall within the
scope of its aims and goals. Alliances are supported through symposia,
informal Think Tanks and seed grants. The Institute also works to identify
and recruit new faculty investigators whose background and experience will
strengthen research programs that the Institute has determine to be
underrepresented, and/or timely.
The action plan for the first year of requested support, January 1998
through December 1998, is summarized as follows. The Institute plans to
continue supporting the seven cores originally funded by the previous
CFAR, Administrative Core, Developmental Core, Virology/BSL3 Tissue
Culture Core, Flow Cytometry/Cell Sorting Core, Mouse/Human Chimera Core,
Clinical Investigations Core, and Gene and Cellular Therapy Core. In
addition, through additional support through the CFAR, the Institute
requests ongoing support for two cores, initiated through finds made
available be private fund-raising efforts, the Mucosal Immunology Core and
Biostatistics Core. Finally, the Institute requests support for three new
cores, an International Core, and two behavioral science cores, and
Adherence to HIV Medication Core, and a Behavioral Adherence, Recruitment
and Retention Core, which together comprise the Health Behavior and
Outreach Program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10160815
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Administrative Core
-
批准号:10614634
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:10468647
-
项目类别:
-
资助金额:$284.77万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:10614633
-
项目类别:
-
资助金额:$284.81万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:10160814
-
项目类别:
-
资助金额:$284.79万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:9890819
-
项目类别:
-
资助金额:$287.22万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Administrative Core
-
批准号:10468648
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
In Vivo Gene Editing for HIV-1 Cure
-
批准号:10549758
-
项目类别:
-
资助金额:$67.8万
-
财政年份:2019
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
In Vivo Gene Editing for HIV-1 Cure
-
批准号:10331787
-
项目类别:
-
资助金额:$67.8万
-
财政年份:2019
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
In Vivo Gene Editing for HIV-1 Cure
-
批准号:9753575
-
项目类别:
-
资助金额:$67.8万
-
财政年份:2019
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Anti-HIV Gene Therapy: Defend and Attack
-
批准号:8899031
-
项目类别:
-
资助金额:$225.61万
-
财政年份:2015
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Anti-HIV Gene Therapy: Defend and Attack
-
批准号:9468343
-
项目类别:
-
资助金额:$195.65万
-
财政年份:2015
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Anti-HIV Gene Therapy: Defend and Attack
-
批准号:9249485
-
项目类别:
-
资助金额:$213.55万
-
财政年份:2015
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Mouse and mathematical models for HIV-1 suppression through HSPC
-
批准号:8915902
-
项目类别:
-
资助金额:$38.1万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:9264595
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:9058597
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:8906934
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Gene engineering using CRISPR/Cas9 mutagenesis to eliminate latent HIV-1
-
批准号:8789998
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:8790285
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Hematopoietic stem/progenitor cell reservoirs
-
批准号:8659761
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2013
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
海外基金